BioCryst Pharmaceuticals Inc

BCRX XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

2.1B

Short interest (May 15)

14.2%

Net Short (Jun 03 ): -0.1%

Borrow Fee

8.15%

↑ 179.0%

Available Shares

↓ 6.7%

Price Chart

Company Overview

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0000882796

Asset Type: CS

Market Data

Market Cap: $2,119,716,584

Employees: 435

Status: Active

Short Interest

Current Borrow Fee 8.15%

Range: 0.91% - 8.15%

Available Shares 5M

Range: 4.4M - 5.8M

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 4.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime